Australia markets closed

Carisma Therapeutics, Inc. (CARM)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
1.3300+0.0200 (+1.53%)
At close: 04:00PM EDT
1.3500 +0.02 (+1.50%)
After hours: 05:21PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-81,215
-86,879
-61,226
-40,784
-28,349
Depreciation & amortisation
3,825
2,837
1,893
682
448
Stock-based compensation
3,108
2,316
275
479
163
Change in working capital
-8,860
-5,436
45,196
1,461
-453
Accounts payable
-2,458
2,191
-473
-974
1,282
Other working capital
-79,082
-82,309
-9,776
-39,199
-27,452
Other non-cash items
5,793
6,850
6,827
834
1,179
Net cash provided by operating activities
-78,068
-81,177
-5,116
-37,328
-27,012
Cash flows from investing activities
Investments in property, plant and equipment
-1,014
-1,132
-4,660
-1,871
-440
Purchases of investments
0
-34,460
-90,900
-
-
Sales/maturities of investments
77,000
108,000
63,000
-
-
Net cash used for investing activities
75,986
72,408
-32,560
-1,871
-440
Cash flows from financing activities
Debt repayment
-2,514
-1,301
-865
-
-
Common stock issued
2,883
31,237
0
-
-
Other financing activities
-4,768
32,057
-922
-366
-
Net cash used provided by (used for) financing activities
-4,210
62,180
33,319
15,962
72,258
Net change in cash
-6,292
53,411
-4,357
-23,237
44,806
Cash at beginning of period
62,807
24,194
28,551
51,788
6,982
Cash at end of period
56,515
77,605
24,194
28,551
51,788
Free cash flow
Operating cash flow
-78,068
-81,177
-5,116
-37,328
-27,012
Capital expenditure
-1,014
-1,132
-4,660
-1,871
-440
Free cash flow
-79,082
-82,309
-9,776
-39,199
-27,452